Hyperproinsulinemia is associated with increased β cell demand after hemipancreatectomy in humans

Journal of Clinical Investigation

Volumn 97, Issue 2, 1996, Pages 455-460

  Seaquist, Elizabeth R ^a,d   Kahn, Steven E ^b   Clark, Penny M ^c   Hales, C Nicholas ^c   Porte Jr , Daniel ^b   Robertson, R Paul ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

diabetes; hemipancreatectomy; insulin; pancreas transplantation; proinsulin

Indexed keywords

GLUCOSE; INSULIN; PROINSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; IMMUNORADIOMETRIC ASSAY; INSULIN BLOOD LEVEL; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0030040425     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118435     Document Type: Article

References (34)

1. Shiraishi, I., Y. Iwamoto, T. Kuzuya, A Matsuda, and S Kumakura. 1991. Hyperinsulinaemia in obesity is not accompanied by an increase in serum proinsulin/insulin ratio in groups of human subjects with and without glucose intolerance. Diabetologia. 34:737-741.
2. Saad, M. F., S. E. Kahn, and R. G Nelson. 1990. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus J. Clin Endocrinol & Metab 70:1247-1253.
3. Persson, B., U Hanson, S G. Hartling, and C. Binder. 1991. Follow-up of women with previous GDM. Insulin, C-peptide, and proinsulin responses to oral glucose load. Diabetes. 40(Suppl 2):136-141.
4. Heaton, D A., B. A Millward, I. P. Gray, Y Tun, C. N Hales, D A. Pyke, and R. D. Leslie 1988 Increased proinsulin levels as an early indicator of B-cell dysfunction in non-diabetic twins of type 1 (insulin-dependent) diabetic patients. Diabetologia. 31:182-184.
5. Hartling, S. G F. Lindgren, G Dahlqvist, and B. Persson. 1989 Elevated proinsulin in healthy siblings of IDDM patients independent of HLA identity Diabetes 38:1271-1274
6. Lindgren, F A , S. G. Hartling, G. G. Dahlquist, C. Binder, S Efendic, and B. E Persson. 1991. Glucose-induced insulin response is reduced and proinsulin response increased in healthy siblings of type 1 diabetic patients Diabetic Med. 8.638-643.
7. Spinas, G A., O. Snorgaard S G. Hartling, M. Oberholzer, and W. Berger. 1992. Elevated proinsulin levels related to islet cell antibodies in first-degree relatives of IDDM patients Diabetes Care 15:632-637.
8. Kahn, S E , D L. Leonetti, R. L. Prigeon, E. J. Boyko, R W Bergstrom, and W. Y Fujimoto. 1995. Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes. 44,173-179.
9. Porte, D Jr., and S. E. Kahn. 1989. Hyperproinsulinemia and amyloid in NIDDM Clues to etiology of islet β-cell dysfunction? Diabetes. 38:1333-1336.
10. Leahy, J. L , P A Halban, and G. C. Weir 1991. Relative hypersecretion of proinsulin in rat model of NIDDM. Diabetes 40:885-889
11. Seaquist, E R , and R. P. Robertson. 1992. Effects of hemipancreatectomy on pancreatic α and β cell function in healthy human donors. J. Clin. Invest. 89:1761-1766.
12. Sutherland, D E 1987. Pancreas transplantation. Diabetes Metab. Rev 3.1061-1090.
13. Kendall, D. M., D E. R. Sutherland, J. S Najarian, F. C. Goetz, and R. P. Robertson. 1990 Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N. Engl. J. Med. 322:898-903.
14. Seaquist, E R., K. Pyzdrowski, A Moran, A. U Teuscher, and R. P Robertson. 1994. Insulin-mediated and glucose-mediated glucose uptake following hemipancreatectomy in healthy human donors. Diabetologia. 37.1036-1043.
15. Halter, J. B , R J. Graf, and D. Porte, Jr. 1979. Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for impaired glucose potentiation. J. Clin. Endocrinol. & Melab. 48:946-954.
16. Ward, W. K , D. C Bolgiano, B. McKnight, J. B. Halter, and D. Porte, Jr. 1984. Diminished B cell secretory capacity in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 74.1318-1328.
17. Morgan, C. R., and A Lazarow. 1963. Immunoassay of insulin, two antibody system. Plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes. 12.115-126.
18. Ward, W K., T. L. Paquette, B. H. Frank, and D. Porte, Jr. 1986. A sensitive radioimmunoassay for human proinsulin. with sequential use of antisera to C-peptide and insulin. Clin Chem. 32.728-733.
19. Rhodes, C J., and C. Alarcón. 1994. What β-cell defect could lead to hyperproinsulinemia in NIDDM? Diabetes. 43:511-517.
20. Sobey, W J., S. F. Beer, C. A. Carrington, P. M. Clark, B H. Frank, I. P. Gray, S. D. Luzio, D. R. Owens, A. E Sehneider, K. Siddle, et al 1989. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem. J. 260:535-541.
21. Neufeld, M., N. K. Maclaren, W. J. Riley, D. Lezottes, J. V. McLaughlin, J. Silverstein, and A. L. Rosenbloom. 1980. Islet cell and other organ-specific antibodies in U.S. Caucasians and Blacks with insulin-dependent diabetes mellitus. Diabetes. 29.589-592.
22. Duckworth, W. C., A. E. Kitabchi, and M. Heinemann. 1972. Direct measurement of plasma proinsulin in normal and diabetic subjects. Am. J. Med. 53:418-427.
23. Gorden, P., C. M. Hendricks, and J. Roth. 1974. Circulating proinsulin-like component in man: increased proportion in hypoinsulinemic states. Diabetologia. 10:469-474.
24. Ward, W. K., E. C LaCava, T. L Paquette, J. C. Beard. B. J. Wallum, and D. Porte. Jr 1987. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30:698-702.
25. Alarcón, C., J. L. Leahy, G. T. Schuppin, and C. J. Rhodes. 1995. Increased secretory demand iather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus J. Clin. Invest. 95.1032-1039.
26. Birkeland, K. I , P. A Torjesen, and J. Eriksson. 1994. Hyperproinsulinemia of type II diabetes is not present before the development of hyperglycemia. Diabetes Care. 17:1307-1310.
27. Kahn, S E , F F. Horber, R. L. Prigeon, and M. W Haymond. 1993. Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans Diabetes. 42:1082-1085.
28. Kahn, S. E., J. C. Beard, M. W. Schwartz, W. K. Ward, H. L. Ding, R N. Bergman, G. J. Taborsky, Jr., and D. Porte, Jr. 1989. Increased β-cell secretory-capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes. 38:562-568.
29. Porte, D , Jr. 1991. β-cells in type II diabetes mellitus. Diabetes. 40:166-180.
30. Barbosa, J., R King, and H. Noreen. 1977. The histocompatibility system in juvenile, insulin-dependent diabetic multiplex kindreds. J Clin. Invest. 60:989-998.
31. Beer, S. F , S. O'Rahilly, R. S Spivey, C. N. Hales, and R. C. Turner 1990. Plasma proinsulin in first-degree relatives of type 2 diabetic subjects. Diabetes Res. 14:51-54.
32. Williams, D. R. R., C. Byrne, P. M. S. Clark, L Cox, N. E. Day, G. Rayman, and T. Wang. 1991. Raised proinsulin concentration as early indicator of β cell dysfunction. Br. Med. J. 303:95-96.
33. Haffner, S. M., R. R. Bowsher, L. Mykkanen, H P. Hazuda, B. D. Mitchell, R. A Valdez, R. Gingerich, A. Monterossa, and M. P. Stern. 1994. Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes. 43:1490-1493.
34. Ward, W. K , B. J Wallum, J. C. Beard, G. J. Taborsky, Jr., and D. Porte, Jr 1988 Reduction of glycemic potentiation. Sensitive indicator of β-cell loss in partially pancreatectomized dogs Diabetes. 37:723-729.